# Haoli

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/haoli

- Industry: Electronics
- Headquarters: Hangzhou, China
- Website: www.haolitech.com
- Total disclosed funding: $1.5M
- Latest round: Angel (Mar 31, 2023)
- Investors on record: 1

## About

Based in Hangzhou, China, and founded in 2022, Haoli is a chip company engaged in the development of microfluidic chips. The company's team members are materials scientists, chemists, microbiologists, and engineers. In March 2025, it closed a venture funding from new investor Yuxi Investment.

Haoli provides users with droplet generators and LNP generators that can be applied in microsphere manufacturing, mass production of drug delivery systems, and synthesis of biomedical particles. The microfluidic chips can handle drug delivery capsules from LNP to micron-level particles that are key carriers for mRNA or small molecule drugs. The company also has production equipment that can produce monodisperse microspheres in the particle size range of 10-100 microns, covering materials such as agarose, dextran, poly-L-lactic acid and polyethylene.

The company generates revenue by providing microfluidic production chips for biopharmaceuticals, medical beauty raw materials, drug delivery, in vitro testing and other fields.

## Funding rounds

- Angel, Mar 31, 2023, $1.5M — Linear Capital

## Investors

- Linear Capital (https://capitalatlas.ai/funds/linear-capital) — Angel